Padmaja Venuturumilli
Expertise in
27
conditions

Dr. Padmaja Venuturumilli

Oncology
Hematology Oncology Consultants
6770 Dixie Hwy, 
Clarkston, MI 
Accepting New Patients
Offers Telehealth
35 Years of Experience
Referral may be required
Expertise in
27
conditions
Hematology Oncology Consultants
6770 Dixie Hwy, 
Clarkston, MI 

Overview

Padmaja Venuturumilli is an Oncologist practicing medicine in Clarkston, Michigan. She has been practicing medicine for over 35 years.

Dr. Venuturumilli is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Chronic Familial Neutropenia, Paget Disease of the Breast, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Vertebroplasty.

Dr. Venuturumilli is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Venuturumilli is currently accepting new patients.

Graduate Institution

NTR University Of Health Sciences, Vijayawada Osmania Medical College, 1991

Residency

Beaumont Hospital

Specialties

Oncology

Licenses

Pediatrics in MI

Board Certifications

American Board Of Internal Medicine

Fellowships

Beaumont Hospital

Hospital Affiliations

Beaumont Hospital - Farmington Hills
Beaumont Hospital - Dearborn
Beaumont Hospital, Troy
Trinity Health Oakland Hospital
Beaumont Hospital Royal Oak
Corewell Health William Beaumont University Hospital
Corewell Health Beaumont Troy Hospital

Languages Spoken

English
Hindi
Kannada
Tamil
Telugu

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Hematology Oncology Consultants
6770 Dixie Hwy, Clarkston, MI 48346
Other Locations
Hematology Oncology Consultants Division of Michigan Healthcare Professionals PC
3577 West 13 Mile Road, Suite 103, Royal Oak, MI 48073
Hematology Oncology Consultants
4550 Investment Drive, Suite B120, Troy, MI 48098
Hematology Oncology Consultants
6770 Dixie Highway, Suite 106A, Clarkston, MI 48346

Additional Areas of Focus

Dr. Venuturumilli has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Methotrexate, Vinblastine, Doxorubicin, Filgrastim
Study Phase: Phase 2
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug
Study Drugs: tucatinib, capecitabine, trastuzumab
Study Phase: Phase 2
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Enrollment Status: Completed
Publish Date: October 28, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

2 Total Publications

Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 05, 2012
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Henry Ford Cancer-Detroit

2800 W Grand Blvd, 
Detroit, MI 
 (11.9 miles away)
888-777-4167
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.

Expertise in
32
conditions
Dr. Rashmi Chugh
Oncology | Hematology | Internal Medicine
Expertise in
32
conditions
Dr. Rashmi Chugh
Oncology | Hematology | Internal Medicine
Referral may be required

Rogel Cancer Center

1500 E Medical Center Dr, Floor B1 Reception E, 
Ann Arbor, MI 
 (31.8 miles away)
734-647-8902
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.

Expertise in
32
conditions
Expertise in
32
conditions
Referral may be required

Henry Ford Medical Center-Columbus

39450 W Twelve Mile Rd, 
Novi, MI 
 (12.6 miles away)
248-344-6688
Languages Spoken:
English, Arabic, Armenian
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Philip is an Oncologist practicing medicine in Novi, Michigan. Dr. Philip is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Pancreatectomy. Dr. Philip is currently accepting new patients.

Frequently Asked Questions about Dr. Padmaja Venuturumilli

How do I make an appointment with Dr. Padmaja Venuturumilli?

You can book an appointment with Dr. Padmaja Venuturumilli by calling their office at 248-288-4500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Padmaja Venuturumilli a top-rated expert for Chronic Familial Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Padmaja Venuturumilli is classified as an Distinguished expert for Chronic Familial Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Padmaja Venuturumilli specialize in?

While Dr. Padmaja Venuturumilli is a Oncology, they have specific expertise in Chronic Familial Neutropenia, Paget Disease of the Breast, and Hemangioma Thrombocytopenia Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Padmaja Venuturumilli participate in research or clinical trials?

Yes. Dr. Padmaja Venuturumilli has published 2 articles and abstracts on conditions like Chronic Familial Neutropenia. You can view a list of Dr. Padmaja Venuturumilli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Padmaja Venuturumilli accept my insurance?

Dr. Padmaja Venuturumilli accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 248-288-4500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Venuturumilli's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 19 Advanced Conditions
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile